— Know what they know.
Not Investment Advice

DNMR OTC

Danimer Scientific, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% 1Y: -91.5% 3Y: -99.5% 5Y: -100.0%
$0.35
Last traded 2025-12-30 — delisted
OTC · Basic Materials · Chemicals - Specialty · $1.1M mcap · 3M float · 1.53% daily turnover · Short 31% of daily vol

Balance Sheet Trends

Total Assets
$698M -2.0% ▼
5Y CAGR: +43.6%
Total Liabilities
$420M +25.5% ▲
5Y CAGR: +37.0%
Shareholders Equity
$278M -26.4% ▼
5Y CAGR: +59.2%
Cash & Investments
$59M -5.8% ▼
5Y CAGR: +56.4%
Total Debt
$408M +30.0% ▲
5Y CAGR: +38.9%
Net Debt
$349M +39.0% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2019FY2020FY2021FY2022FY2023
— Assets —
Cash$6M$378M$286M$63M$59M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$6M$378M$286M$63M$59M
Net Receivables$6M$8M$25M$24M$19M
Inventory$7M$14M$25M$33M$25M
Other Current Assets$0$0$0$5M$5M
Total Current Assets$19M$402M$340M$125M$108M
Property, Plant & Equip.$92M$126M$335M$473M$464M
Goodwill & Intangibles$2M$2M$147M$81M$78M
Long-Term Investments$31M$16M-$1M$33M$46M
Other Non-Current Assets$31M$16M$16M$26K$2M
Total Non-Current Assets$125M$144M$498M$587M$590M
Total Assets$145M$546M$839M$712M$698M
— Liabilities —
Accounts Payable$8M$11M$21M$15M$5M
Short-Term Debt$9M$25M$357K$2M$1M
Deferred Revenue$5M$2M$214K$200K$1M
Other Current Liabilities$1M$5M$14M$889K$2M
Total Current Liabilities$34M$50M$43M$25M$16M
Long-Term Debt$74M$31M$261M$286M$381M
Other Non-Current Liab.$2M$84M$10M$659K$1M
Total Non-Current Liabilities$94M$140M$295M$309M$404M
Total Liabilities$128M$107M$338M$335M$420M
— Equity —
Common Stock$3K$8K$10K$10K$10K
Retained Earnings-$50M-$59M-$119M-$299M-$454M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity$17M$356M$500M$378M$278M
Total Liabilities & Equity$145M$546M$839M$712M$698M
— Key Metrics —
Total Debt$103M$84M$287M$314M$408M
Net Debt$97M-$294M$834K$251M$349M
Total Investments$31M$16M-$1M$33M$46M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms